Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present GenMark Diagnostics, Inc. (NASDAQ: GNMK).

Full DD Report for GNMK

You must become a subscriber to view this report.


Recent News from (NASDAQ: GNMK)

Analysis: Positioning to Benefit within Cirrus Logic, Aaron's, Waste Connections, Shake Shack, R.R. Donnelley & Sons, and GenMark Diagnostics - Research Highlights Growth, Revenue, and Consolidated Results
NEW YORK, May 14, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Cirrus Logic, Inc. (NASDAQ:CRUS), Aaron's, Inc. (NYSE:AAN), Waste Connecti...
Source: GlobeNewswire
Date: May, 14 2018 08:15
Week 20 Breakout Forecast: Short-Term Picks To Give You An Edge
Breakout Forecast Selections for Week 20: Market conditions continue with high volatility. The positive momentum gauge spent another full week in yellow (medium) moving from a value of 61 last week up to a value of 66 this week. The all time low for the positive momentum selection gauge is 8...
Source: SeekingAlpha
Date: May, 14 2018 07:59
GenMark Diagnostics to Present at the Bank of America Merrill Lynch 2018 Health Care Conference
CARLSBAD, Calif., May 02, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK) a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that President and Chief Executive Officer, Hany Massarany, will present at the Bank of America Merrill...
Source: GlobeNewswire
Date: May, 02 2018 16:03
GenMark Diagnostics' (GNMK) CEO Hany Massarany on Q1 2018 Results - Earnings Call Transcript
GenMark Diagnostics, Inc. (GNMK) Q1 2018 Earnings Conference Call May 01, 2018, 04:30 PM ET Executives Johnny Ek - Corporate Controller Hany Massarany - President and CEO Scott Mendel - CFO Analysts Mark Massaro - Canaccord Genuity. Tycho Peterson - JPMorgan Doug Schenk...
Source: SeekingAlpha
Date: May, 01 2018 20:05
GenMark Diagnostics beats by $0.01, beats on revenue
GenMark Diagnostics (NASDAQ: GNMK ): Q1 EPS of -$0.21 beats by $0.01 . More news on: GenMark Diagnostics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: May, 01 2018 16:18
GenMark Diagnostics Reports First Quarter 2018 Results
CARLSBAD, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the first quarter ended March 31, 2018. Highlights Revenues of $20.6 mil...
Source: GlobeNewswire
Date: May, 01 2018 16:05
Midday Gainers / Losers (04/18/2018)
Gainers: VTVT +97% . IZEA +27% . EPE +18% . TLGT +17% . DCAR +14% . LX +14% . AQMS +13% . MCEP +13% . WTI +12% . GNMK +12% . More news on: vTv Therapeutics, IZEA Inc., EP Energy Corporation, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: April, 18 2018 12:40
GenMark Diagnostics Schedules First Quarter Financial Results Conference Call for May 1, 2018
CARLSBAD, Calif., April 17, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it plans to release its first quarter earnings results after market close on Tuesday, May 1, 2018. Management will hold a conference call to review the Company's financial ...
Source: GlobeNewswire
Date: April, 17 2018 16:03
Snap Is Going Nowhere - Cramer's Lightning Round (4/9/18)
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Monday, April 9. Bullish Calls HP, Inc (HPQ): It's doing terrific and Cramer recommended buying at $20. Advanced Micro Devices (AMD): It doesn't deserve to go down due to bitcoin. Buy under $10. DowDuP...
Source: SeekingAlpha
Date: April, 10 2018 06:29
Week 12 Breakout Forecast: Short-Term Picks To Give You An Edge
Breakout Forecast Selections for Week 12: Market conditions continue with extreme volatility. My momentum gauge dropped throughout the past week to a value of 38 down significantly from the prior week 11 at a value of 57. Volatility in the market remains at high levels and we have not been a...
Source: SeekingAlpha
Date: March, 18 2018 12:49

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-176.926.897.026.85175,717
2018-02-264.174.534.664.17712,807
2018-02-234.294.254.304.12190,928
2018-02-224.434.254.514.115333,136
2018-02-214.424.464.624.37152,675

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-05-2514,10044,25331.8622Cover
2018-05-2471,788315,05022.7862Cover
2018-05-2321,24448,80743.5265Short
2018-05-2217,29746,75436.9958Short
2018-05-2112,08447,79425.2835Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on GNMK.


About GenMark Diagnostics, Inc. (NASDAQ: GNMK)

Logo for GenMark Diagnostics, Inc. (NASDAQ: GNMK)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: GNMK)

      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: May, 01 2018
      Quarterly report with a continuing view of a company's financial position
      Filing Type: 10-QFiling Source: edgar
      Filing Date: May, 01 2018
      Official notification to shareholders of matters to be brought to a vote (Proxy)
      Filing Type: DEF 14AFiling Source: edgar
      Filing Date: April, 13 2018
      Additional proxy soliciting materials - definitive
      Filing Type: DEFA14AFiling Source: edgar
      Filing Date: April, 13 2018
      Filing Type: CT ORDERFiling Source: edgar
      Filing Date: March, 27 2018
      Filing by person(s) reporting owned shares of common stock in a public company >5%
      Filing Type: SC 13DFiling Source: edgar
      Filing Date: March, 27 2018
      Securities offered to employees under employee benefit plans
      Filing Type: S-8Filing Source: edgar
      Filing Date: March, 01 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: March, 01 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: February, 27 2018
      Annual report with a comprehensive overview of the company
      Filing Type: 10-KFiling Source: edgar
      Filing Date: February, 27 2018

       

       


      Daily Technical Chart for (NASDAQ: GNMK)

      Daily Technical Chart for (NASDAQ: GNMK)


      Stay tuned for daily updates and more on (NASDAQ: GNMK)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: GNMK)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      The Subway Trader
      @TheSubwayTrader

       

       


      Disclaimer: The Subway Trader publishes reports providing information on selected companies. The Subway Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. The Subway Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in GNMK is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. The Subway Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. The Subway Trader does not own any shares of GNMK and does not buy, sell, or trade any shares of GNMK. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by The Subway Trader. All rights reserved. Our Full Disclaimer: http://thesubwaytrader.com/disclaimer/